about
miR-380-5p-mediated repression of TEP1 and TSPYL5 interferes with telomerase activity and favours the emergence of an "ALT-like" phenotype in diffuse malignant peritoneal mesothelioma cells.A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas.Mass spectrometry-based assay for the molecular diagnosis of glioma: concomitant detection of chromosome 1p/19q codeletion, and IDH1, IDH2, and TERT mutation status.Telomeres and Telomerase in Hematopoietic Dysfunction: Prognostic Implications and Pharmacological Interventions.The Emerging Roles for Telomerase in the Central Nervous System.
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Telomerase inhibitors: a patent review (2010-2015).
@en
type
label
Telomerase inhibitors: a patent review (2010-2015).
@en
prefLabel
Telomerase inhibitors: a patent review (2010-2015).
@en
P2093
P2860
P1476
Telomerase inhibitors: a patent review (2010-2015).
@en
P2093
Hai-Liang Zhu
Long-Wang Chen
Ruo-Jun Man
P2860
P304
P356
10.1080/13543776.2016.1181172
P407
P577
2016-04-22T00:00:00Z